Brian Feroldi

Brian Feroldi


Brian Feroldi has been covering the healthcare industry for the Motley Fool since 2015. Brian's investing goal is to find the highest quality companies that he can find, buy them, and then to sit back and let compounding work its magic. See all of his articles here and make sure you follow him on Twitter.

Recent articles

Why Accuray Is Soaring Today

Shares pop after the company reports upbeat fourth-quarter results. Here's what investors need to know.

NIC Takes on the Opioid Epidemic

Favorable operating leverage allows NIC's quarterly net income to surge, but the launch of a brand-new prescription-drug monitoring program takes center stage in its second-quarter earnings report.

Horizon Global Remains in Turnaround Mode

All of the company's key figures are trending in the wrong direction, but management remains steadfast in its belief that the planned turnaround is taking hold.

Infinera's Turnaround Continues to Take Hold

Infinera's headline numbers are trending in the right direction, and management believes that its pending acquisition of Coriant will be a transformative event.